Dublin, Aug. 09, 2017 (GLOBE NEWSWIRE) -- The "Global Next Generation Implants (NGI) Market -Analysis and Forecast (2017-2023) - Market Share Analysis and Competitive Insights" report has been added to Research and Markets' offering.

The global next generation implants market is estimated to grow over $3.9 billion by 2023. On the other hand, the conventional implants market is estimated to grow over $103 billion in 2023.

On the basis of application, the market is segmented into orthopedic, cardiovascular, dental, ocular and other implants. As per the raw material, the metals and its alloys are dominating the conventional implants market with an estimated value of $25 billion in 2016.

North America was estimated to be the leader in 2016 in conventional implants with a market value of $30 billion in 2016 mainly due to rising geriatric population and increased prevalence of diseases. The fastest growing market is expected to Asia Pacific with a CAGR of 8.7% from 2017 to 2023. The market is strongly driven by the technological advancement & evolution of implants. The use of better materials, automated surgeries, biological materials, personalised implants, better care, and decreased risk of infection are contributing to increased patients' and physicians' interest in the market.

The medical implants market is a large market with implants for various applications. As the world population is ageing, the prevalence of age related degenerating diseases is increasing. As per World Health Organization (WHO), the number of people aged 60 years & above will rise to 1.4 billion by 2030. Due to increase in the geriatric population & improved life expectancy, the number of age related diseases has also increased. This is the major contributor to the increased demand of the medical implant devices. The devices can be of permanent or temporary nature depending on the application.

The medical implants can be categorised based on the application into orthopaedic, cardiovascular, ocular, dental and others. These implants can be made of different raw materials such as metals and its alloys, ceramics, polymers, biologicals and others. The market analysis includes an in-depth examination of the key ecosystem players and key strategies & developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities and challenges) and industry analysis.

The key players which have significant contributions to the biologics drug discovery market are Smith & Nephew plc, Orthofix Holdings, Inc. Medtronic Public Limited Company, LivaNova PLC, Edwards Lifesciences Corporation, Globus Medical Inc., Johnson & Johnson and Zimmer Biomet Holdings Inc. among others.

The answers to the following key questions can be derived from this report:

• What are the major market drivers, challenges and opportunities in the global next generation implants market and their case studies?
• How the medical implants market evolve and what is its scope in the future?
• What is the market share of the leading segments and sub-segments of the global next generation implants market in 2016 and 2023?
• How will each segment of the global next generation implants market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2023?
• What are the influencing factors that may affect the market share of the key players?
• How will the industry evolve during the forecast period between 2016 and 2023?
• What are the key developmental strategies implemented by the key players to stand out in this market?
• What will be the growth rate of different segments during the forecast period? Which is the leading segment by application and raw material used?
• Who are the key players for the next generation of implants market?
• How the market has been segmented on the basis of application?
• Which geographical location will dominate the next generation implants market?

Key Topics Covered:

Executive Summary

1 Report Scope
1.1. Scope of the Report
1.2. Global Next Generation Implant Market Segmentation
1.3 Key Learnings
1.4 Research Methodology

2 Market Overview
2.1 Introduction
2.2 Characteristics of Implant
2.3. Recent Advancements

3 Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

4 Industry Insights
4.1 Regulatory Scenario
4.2. Patent Landscape

5 Competitive Landscape
5.1. Share of Key Development and Strategies
5.2. Porter's Five Forces Analysis
5.3. Value Chain Analysis

6 Global Next Generation Implants Market, by Application
6.1. Market Overview
6.1.1. Orthopedic Implants
6.1.2. Cardiovascular Implants
6.1.3. Ocular Implants
6.1.4. Dental Implants
6.1.6. Others

7 Global Next Generation Implants Market, by Material
7.1. Introduction
7.2. Characteristics
7.3. Metals & Metal Alloys
7.4. Ceramics
7.5. Polymers
7.6. Biologics
7.7 Others

8 Global Next Generation Implants Market, by Geography

9 Company Profiles

• Abbott Laboratories
• Arthrex
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• C. R. Bard, Inc.
• Danaher Corporation
• Dentsply Sirna Inc.
• Edwards Lifesciences Corporation
• Endo International Plc
• Globus Medical Inc.
• Integer Holdings Corporation
• Integra Lifesciences Corporation
• Institut Straumann AG
• Johnson & Johnson
• Lifenet Health, Inc.
• Livanova Plc
• Medtronic Public Limited Company
• Novartis International Ag
• Nuvasive, Inc.
• Orthofix Holdings, Inc.
• Smith & Nephew Plc
• Stryker Corporation
• Symetis SA
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Wright Medical Group N.V
• Zimmer Biomet Holdings Inc

For more information about this report visit https://www.researchandmarkets.com/research/6qrkvf/global_next

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Medical Devices